MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1705339 CAUSEWAY BAY, K3

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$557,542

-$116,972 QoQ

Shares Held

124,730

+1.7% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $430,178,526 across 240 Biotechnology names. TSHA ranks #109 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	171,925	$76,771,388
2	REGN	Regeneron Pharmaceuticals, Inc.	69,854	$53,971,993
3	ALNY	Alnylam Pharmaceuticals, Inc.	81,325	$26,908,001
4	INSM	INSMED Inc	122,958	$20,106,091
5	RPRX	Royalty Pharma plc	419,129	$20,105,617
6	PRAX	Praxis Precision Medicines, Inc.	27,744	$8,938,838
7	ARWR	Arrowhead Pharmaceuticals, Inc.	139,598	$8,752,793
8	MRNA	Moderna, Inc.	147,589	$7,497,520

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$557,542	124,730	+1.7%	Shares	Defined	2026-05-15
2025-12-31	$674,514	122,639	+10.5%	Shares	Defined	2026-02-17
2025-09-30	$363,047	111,024	+15.0%	Shares	Defined	2025-11-14
2025-06-30	$223,014	96,543	-6.3%	Shares	Defined	2025-08-14
2025-03-31	$143,272	103,074	-5.1%	Shares	Defined	2025-05-15
2024-12-31	$187,884	108,604	+23.3%	Shares	Defined	2025-02-14
2024-09-30	$176,986	88,053	—	Shares	Defined	2024-11-14
No filing history on record for this holder in this stock.